Showing results (211-220 of 283) with videos related to
Sort By:
Pageof 29
Gynecologic Oncology|December 1, 1994
In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcomeM Federico, D S Alberts, D J Garcia, et al.The Journal of Clinical Endocrinology and Metabolism|March 1, 1979
Radioiodine in the treatment of medullary carcinoma of the thyroidD E Hellman, M Kartchner, J D Van Antwerp, et al.The American Journal of Medicine|November 1, 1980
Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain depositionJ L Preud'homme, L Morel-Maroger, J C Brouet, et al.British Journal of Haematology|January 1, 1985
The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patientsJ C Brouet, J P Fermand, G Laurent, et al.Blood|October 1, 1991
Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpuraF Louache, A Bettaieb, A Henri, et al.Nature|November 7, 1991
A new type of synthetic peptide library for identifying ligand-binding activityK S Lam, S E Salmon, E M Hersh, et al.Journal of Medicinal Chemistry|February 13, 1999
Novel antitumor 2-cyanoaziridine-1-carboxamidesB S Iyengar, R T Dorr, D S Alberts, et al.American Journal of Clinical Oncology|April 1, 1992
A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group studyD S Alberts, N Mason-Liddil, D Stock-Novack, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1977
Nabilone: a potent antiemetic cannabinol with minimal euphoriaT S Herman, S E Jones, J Dean, et al.Investigational New Drugs|January 1, 1984
Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide)D S Alberts, J G Einspahr, R Struck, et al.Pageof 29